The timeline for consultation on an update to a NICE guideline on type 2 diabetes management has been amended.
The draft guideline consultation for Type 2 diabetes in adults: management (medicines update) NG28 willnow begin on Wednesday, August 20 and end on Thursday, October 2, with the final publication date to be confirmed.
Generic versions of dapagliflozin have entered the market after a court ruling invalidated AstraZeneca’s patent for the SGLT2 inhibitor.
The UK Court of Appeal has dismissed AstraZeneca’s challenge to a previous High Court ruling, upholding the decision to invalidate the company’s patent and supplementary protection certificates (SPCs) for its type 2 diabetes treatment dapagliflozin (Forxiga).
A new subtype of diabetes has been identified in children and young people in sub-Saharan Africa.
The new finding, published in The Lancet Diabetes & Endocrinology and funded by the UK’s National Institute for Health and Care Research (NIHR), challenges the global understanding of diabetes in young people.
New research has identified a growing confidence among UK nurses and midwives in supporting people with diabetes using continuous glucose monitoring (CGM) technologies, but not so much hybrid closed-loop (HCL) systems.
While the widespread adoption of CGM is now underpinned by relatively high staff confidence and training access, HCL implementation remains inconsistent, particularly outside of specialist diabetes teams, a national online survey has revealed.
Leicester Diabetes Centre has launched an updated version of its Insulin Education Toolkit, developed to support healthcare professionals delivering safe and effective insulin therapy across the UK.
Last published and updated in 2018, the Toolkit has now been refreshed for 2025 to reflect the latest NICE guidance and clinical best practice.
Hypo Awareness Week is back from October 6 to 12, bringing together HCPs from across the UK and Ireland to highlight the dangers of hypoglycaemia. To read more, click here.
Experts in diabetic neuropathy will share their research and specialist knowledge at NEUROdiab’s35th Annual Meeting in September. To read more, click here.
Spirit Health has announced the launch of a new digitally connected support service for people living with diabetes who are switching to the CareSens Air CGM. To read more, click here.
NerveCheck Master could be a potential new screening tool for cardiac autonomic neuropathy, following promising results from a recent study. To read more, click here.
Three new Board Directors will join Breakthrough T1D UK later this year.
Steve Bates OBE, David Bruce and Dean Sowman have been appointed to strengthen the organisation’s scientific research, communications and financial expertise within its existing Board.
This analysis included data on 60,287 people with type 2 diabetes and follow up was seven years on average. To read more, click here.
The Spirit Health Foundation is urging supporters to dig deep and donate to its 2025 Ben Nevis fundraising challenge. To read more, click here.
Bringing you the latest jobs from around the country within the field of diabetes.
Lead Clinical Nurse Specialist in Diabetes – University Hospitals Birmingham NHS Foundation Trust
Paediatric Diabetes Specialist Nurse – Manchester University NHS Foundation Trust
Paediatric Diabetes Specialist Dietitian – East Kent Hospitals University NHS Foundation Trust
Diabetes Specialist Nurse – Whittington Hospital NHS Trust
Join the expanding diabetes community on X and follow us for the latest diabetes news updates at @DiabetesTimes.
We are now on YouTube where you will find interviews with leading figures within the field of diabetes. Click here to visit our page.
